ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

RYZB RayzeBio Inc

62,49
0,00 (0,00%)
Vor Marktöffnung
Zuletzt aktualisiert: 02:00:00
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
RayzeBio Inc RYZB NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
0,00 0,00% 62,49 02:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
62,49
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
07.3.202422:07EDGAR2Form 15-12G - Securities registration termination [Section..
27.2.202422:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27.2.202422:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26.2.202415:20EDGAR2Form S-8 POS - Securities to be offered to employees in..
26.2.202415:20EDGAR2Form 8-K - Current report
23.2.202413:53EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
23.2.202412:59BWBristol Myers Squibb Announces Expiration of RayzeBio Tender..
14.2.202415:19EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
12.2.202414:54EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
12.2.202412:59BWBristol Myers Squibb and RayzeBio Announce Expiration of HSR..
07.2.202400:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25.1.202414:53EDGAR2Form SC 14D9 - Solicitation, recommendation statements
08.1.202416:06PRNUSKuehn Law Encourages KRTX, DSKE, RYZB, and GRCL Investors to..
27.12.202322:15EDGAR2Form SC14D9C - Written communication relating to third party..
26.12.202323:08EDGAR2Form SC14D9C - Written communication relating to third party..
26.12.202316:28DJNTrending: Bristol Myers Squibb to Buy RayzeBio
26.12.202314:32EDGAR2Form SC14D9C - Written communication relating to third party..
26.12.202314:26EDGAR2Form 8-K - Current report
26.12.202314:04DJNRayzeBio Shares Soar Premarket on Takeover by Bristol Myers
26.12.202313:46DJNBristol Myers Squibb to Buy RayzeBio for $4.1 Billion
26.12.202313:13GLOBEBristol Myers Squibb Adds Premier Radiopharmaceutical..
26.12.202312:59BW Bristol Myers Squibb Adds Premier Radiopharmaceutical..
18.11.202300:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18.11.202300:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.11.202322:04EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13.11.202322:03EDGAR2Form 8-K - Current report
13.11.202322:01GLOBERayzeBio Reports Third Quarter 2023 Financial Results and..
06.11.202322:05GLOBERayzeBio to Participate in Upcoming Investor Conferences in..
01.11.202314:14EDGAR2Form 8-K - Current report
01.11.202311:00GLOBERayzeBio Appoints Industry Leader Tim Van Hauwermeiren to..
24.10.202314:00GLOBEFDA selects RayzeBio to Participate in the Inaugural CDRP..
18.10.202313:00GLOBERayzeBio to Present at European Society for Medical Oncology..
19.9.202322:01BWRayzeBio, Inc. Announces Closing of Upsized $358 Million..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock